Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1997-8-7
|
pubmed:language |
heb
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0017-7768
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
132
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
643-8
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:9225580-Hepatitis C,
pubmed-meshheading:9225580-Humans,
pubmed-meshheading:9225580-Interferons,
pubmed-meshheading:9225580-Interleukin-2,
pubmed-meshheading:9225580-Predictive Value of Tests,
pubmed-meshheading:9225580-Prognosis,
pubmed-meshheading:9225580-Receptors, Interleukin-1
|
pubmed:year |
1997
|
pubmed:articleTitle |
[Hepatitis C, therapy and predicting factors].
|
pubmed:publicationType |
Journal Article,
Review
|